Original news and analysis on international IP policy
A recent book comes in time for the international policy debates coming to a head over access to medicines, intellectual property rights and public health in developing countries.
An international convention on research and development for neglected diseases has never been so closely within reach. A World Health Organization expert group is recommending the implementation of a legally binding instrument to secure new sources of funding to spur health research in areas where the current system has failed.
Executive Director Ellen 't Hoen is departing the Medicines Patent Pool, the cutting edge UN spin-off project that works to lower prices on and stimulate new development of HIV medicines and other products through negotiating voluntary licence agreements. According to a release, 't Hoen has fulfilled the mission of guiding the organisation from a startup onto "firm footing" and has informed the Board that she will leave on 1 May.
Pressure is growing in Europe for open, free access to research results, particularly if they are publicly funded. The European Commission (EC) said this week it will propose a plan for open access soon, while the Wellcome Trust and Research Councils UK are cracking down on researchers who don't comply with their policies.
It’s unclear if the US Supreme Court wants to address yet another controversial issue in patent law, but on 2 April, the court took a small step in that direction. That’s when the court formally asked the US Justice Department to opine on whether the high court should grant certiorari in Bowman v. Monsanto Co.
Intellectual property-intensive industries in the United States support at least 40 million jobs and contribute more than $5 trillion - or 34.8 percent of - US gross domestic product (GDP), according to a report released by the Obama administration Wednesday.
In response to a report published on 3 April by civil society group No Patent on Seeds alleging that industry and patent examiners in the European Patent Office are finding legal loopholes to grant patents on seeds and plants, an EPO spokesperson told Intellectual Property Watch the patent office does not "apply tricks" to grant patents.
The United States is known for taking an unusually expansive approach towards patentable subject matter. Compared with Western Europe, for instance, the US has been far readier to grant patents on business methods, medical diagnostic processes, and human genes.
A recently published book by Harvard Law School Professor John Palfrey offers a thoughtful and useful handbook for executives or just about anyone else to better understand and use intellectual property, in ways that encourage sharing and openness.
A new report by civil society group No Patent on Seeds was issued yesterday alleging that industry and patent examiners in the European Patent Office are "using legal loopholes to grant patents on seeds, plants and even harvest and food products derived thereof."
Using on-the-ground research in Africa and the Netherlands, the authors of a recent book looked at the impact of intellectual property on agriculture and health in developing countries. The study made some surprise findings in relation to IP and development, such as IP-related obstacles to knowledge and technology transfer.
The Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis' challenge of India's patent law until July, according to sources.